Latest Period
Q1 2026
Security Snapshot
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) Institutional Ownership
CUSIP: 690469101
13F Institutional Holders and Ownership History from Q2 2017 to Q1 2026
Institutions Reporting
103
Shares (Excl. Options)
105,065,946
Price
$2.22
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- OVID on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 105,065,946
- Total 13F value
- $233,184,546
- Portfolio coverage rank
- 0%
- Share change
- +40,375,633
- Value change
- +$91,068,941
- Number of holders
- 103
- Shares outstanding
- 146,457,154
- SEC-reported price per share
- $2.79
- Insider filing price
- $2.79
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 690469101.
- 103 institutions reported positions in Q1 2026.
- 14 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 83 to 103 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $100,169,419 to $233,184,546.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 103 institutions filings for Q1 2026.
Security key
690469101
Latest holder period
Q1 2026
13F holders
103
13D/G owners
14
CIK / CUSIP context first
Open Q1 2026 holders
OVID full holder history
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Ovid Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 690469101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
14
Security
OVID
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sirenia Capital Management LP | 9.9% | $51,930,239 | 18,031,333 | Sirenia Capital Management LP | 31 Mar 2026 | |||
| Affinity Asset Advisors, LLC | 9.1% | +1.1% | $45,030,194 | +$10,040,596 | 15,635,484 | +29% | Affinity Asset Advisors, LLC | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $19,889,602 | 13,259,735 | RA Capital Management, L.P. | 11 Dec 2025 | |||
| EVENTIDE ASSET MANAGEMENT, LLC | 7.3% | $36,787,902 | 12,773,577 | Eventide Asset Management, LLC | 31 Mar 2026 | |||
| ADAR1 Capital Management, LLC | 6.9% | $14,111,932 | 9,284,166 | ADAR1 Capital Management, LLC | 31 Dec 2025 | |||
| TAKEDA PHARMACEUTICAL CO LTD | 12% | $11,680,055 | 8,781,996 | Takeda Pharmaceutical Company Limited | 08 Dec 2025 | |||
| LEVIN JEREMY M | 4.5% | $24,628,326 | 8,551,502 | Jeremy M. Levin | 31 Mar 2026 | |||
| FEDERATED HERMES, INC. | 5.9% | $12,611,581 | 7,737,166 | Federated Hermes, Inc. | 31 Dec 2025 | |||
| JANUS HENDERSON GROUP PLC | 10% | $9,461,772 | 7,114,114 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 5.3% | $20,244,162 | 7,029,223 | Balyasny Asset Management L.P. | 31 Mar 2026 | |||
| Madison Avenue Partners, LP | 4% | $969,800 | 2,852,352 | Madison Avenue Partners, LP | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 1.3% | -76% | $5,483,356 | -$13,891,006 | 1,903,943 | -72% | Point72 Asset Management, L.P. | 31 Mar 2026 |
| BlackRock, Inc. | 1.9% | $451,636 | 1,369,010 | BlackRock, Inc. | 30 Jun 2025 | |||
| Rubric Capital Management LP | 0.67% | $153,131 | 478,533 | Rubric Capital Management LP | 30 Jun 2025 |
As of 31 Mar 2026, 103 institutional investors reported holding 105,065,946 shares of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID). This represents 72% of the company’s total 146,457,154 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
65%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.3% | 10,714,000 | 0% | 0.25% | $23,785,080 |
| JANUS HENDERSON GROUP PLC | 7.3% | 10,714,000 | 0.01% | $23,731,510 | |
| Affinity Asset Advisors, LLC | 7.3% | 10,636,318 | +49% | 1.4% | $23,612,626 |
| EVENTIDE ASSET MANAGEMENT, LLC | 6.8% | 9,916,911 | +131% | 0.36% | $22,015,542 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.2% | 6,163,781 | +77% | 0.02% | $13,683,594 |
| Balyasny Asset Management L.P. | 3.8% | 5,533,073 | +1602% | 0.02% | $12,283,422 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 5,258,246 | 0% | 0% | $11,673,306 |
| ADAR1 Capital Management, LLC | 3.1% | 4,544,113 | +6% | 0.61% | $10,087,931 |
| Saturn V Capital Management LP | 2.8% | 4,166,666 | +67% | 1.7% | $9,249,999 |
| FEDERATED HERMES, INC. | 2.4% | 3,571,000 | 0% | 0.01% | $7,927,620 |
| Ikarian Capital, LLC | 2% | 2,894,704 | +1069% | 0.92% | $6,426,242 |
| Ally Bridge Group (NY) LLC | 1.9% | 2,818,459 | +58% | 6.2% | $6,256,979 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.3% | 1,947,594 | +470% | 0.01% | $4,323,659 |
| Blue Owl Capital Holdings LP | 1.3% | 1,904,666 | 1.1% | $4,228,359 | |
| SPHERA FUNDS MANAGEMENT LTD. | 1.1% | 1,622,828 | 0.62% | $3,602,678 | |
| BlackRock, Inc. | 1% | 1,533,283 | +150% | 0% | $3,403,888 |
| MILLENNIUM MANAGEMENT LLC | 1% | 1,496,518 | +12% | 0% | $3,322,270 |
| Point72 Asset Management, L.P. | 0.9% | 1,320,610 | -63% | 0.01% | $2,931,754 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 1,318,091 | +96% | 0% | $2,927,792 |
| TWO SIGMA INVESTMENTS, LP | 0.86% | 1,256,869 | +110% | 0% | $2,790,249 |
| Sio Capital Management, LLC | 0.86% | 1,252,381 | -12% | 0.4% | $2,780,286 |
| Rosalind Advisors, Inc. | 0.76% | 1,107,994 | 1% | $2,459,747 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.75% | 1,104,300 | -26% | 0% | $2,451,546 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.68% | 1,000,000 | 0.26% | $2,220,000 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.63% | 927,913 | +496% | 0.05% | $2,059,967 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
36
Latest
Q1 2026
Rows shown
1-25 of 36
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 105,065,946 | $233,184,546 | +$91,068,941 | $2.22 | 103 |
| 2025 Q4 | 61,768,473 | $100,169,419 | +$54,659,119 | $1.63 | 83 |
| 2025 Q3 | 36,211,271 | $47,075,130 | +$6,613,712 | $1.30 | 80 |
| 2025 Q2 | 35,963,686 | $11,861,338 | -$3,392,024 | $0.33 | 69 |
| 2025 Q1 | 46,399,305 | $14,469,971 | -$2,823,886 | $0.31 | 81 |
| 2024 Q4 | 47,565,663 | $44,391,185 | +$933,718 | $0.93 | 80 |
| 2024 Q3 | 46,326,650 | $54,661,169 | -$2,312,497 | $1.18 | 75 |
| 2024 Q2 | 46,022,725 | $35,395,023 | -$20,868,716 | $0.77 | 72 |
| 2024 Q1 | 50,111,416 | $152,838,625 | -$4,734,653 | $3.05 | 80 |
| 2023 Q4 | 51,658,816 | $166,339,097 | +$8,163,314 | $3.22 | 77 |
| 2023 Q3 | 42,343,665 | $162,598,117 | +$5,682,119 | $3.84 | 64 |
| 2023 Q2 | 41,007,449 | $134,502,613 | +$8,714,482 | $3.28 | 69 |
| 2023 Q1 | 38,694,424 | $99,783,463 | +$651,350 | $2.58 | 60 |
| 2022 Q4 | 38,559,195 | $71,717,529 | +$2,582,813 | $1.86 | 58 |
| 2022 Q3 | 35,588,862 | $65,480,293 | +$1,720,712 | $1.84 | 55 |
| 2022 Q2 | 34,628,854 | $74,450,307 | -$3,009,412 | $2.15 | 52 |
| 2022 Q1 | 35,130,112 | $110,307,198 | +$3,432,314 | $3.14 | 61 |
| 2021 Q4 | 34,014,426 | $109,179,202 | +$1,236,530 | $3.21 | 65 |
| 2021 Q3 | 33,589,442 | $112,862,212 | -$90,780 | $3.36 | 70 |
| 2021 Q2 | 33,366,478 | $130,460,427 | -$11,009,099 | $3.91 | 76 |
| 2021 Q1 | 36,251,183 | $145,725,613 | +$42,574,480 | $4.02 | 85 |
| 2020 Q4 | 27,412,279 | $63,321,129 | -$6,383,233 | $2.31 | 75 |
| 2020 Q3 | 25,114,493 | $144,162,828 | +$11,138,040 | $5.74 | 90 |
| 2020 Q2 | 21,848,899 | $161,034,711 | +$48,530,099 | $7.37 | 78 |
| 2020 Q1 | 15,867,223 | $47,289,209 | -$7,210,519 | $2.98 | 56 |